SPRO Earnings Spero Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.13 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | 0.15 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.41 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.28 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.25 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -1.27 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.89 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.57 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.24 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | 0.43 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -0.54 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.48 | 2024-08-05 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.25 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -1.23 | 2024-03-13 | 10-K |
| Q3 2023 | 2022-09-30 | -2.16 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.88 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.01 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.91 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -1.99 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.29 | 2022-08-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.